2025-05-19 – Press Releases – www.prnewswire.com
SAN FRANCISCO and SUZHOU, China, May 19, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic,…
